{"id":197060,"name":"BROWN RUDNICK, LLP, ON BEHALF OF LUPIN PHARMACEUTICALS, INC.","slug":"brown-rudnick-llp-on-behalf-of-lupin-pharmaceuticals-inc","state":"DC","country":"United States of America","description":"Law Firm","totalSpending":40000,"filings":7,"yearlySpending":[{"year":2018,"income":40000},{"year":2019,"income":0}],"issues":["TAX","HCR"],"firms":["HOOPER, LUNDY & BOOKMAN, P.C."],"lobbyists":["MARTIN CORRY","LISA LAYMAN"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["H.R. 2051 - The FAST Generics Act; H.R. 2212 - CREATES Act of 2017; H.R. 749 - The Lower Drug Costs Through Competition Act; H.R. 2430 - FDA Reauthorization Act of 2017; border adjustability tax","H.R. 2051 - The FAST Generics Act; H.R. 2212 - CREATES Act of 2017; H.R. 749 - The Lower Drug Costs Through Competition Act; H.R. 2430 - FDA Reauthorization Act of 2017; border adjustability tax","H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.","H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act.","H.R. 2212 & S. 974-The Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act."],"years":[2018,2019]}